J O'donnell

2.8k total citations
62 papers, 1.8k citations indexed

About

J O'donnell is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J O'donnell has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Rheumatology, 18 papers in Immunology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J O'donnell's work include Rheumatoid Arthritis Research and Therapies (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Vasculitis and related conditions (9 papers). J O'donnell is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Vasculitis and related conditions (9 papers). J O'donnell collaborates with scholars based in New Zealand, United States and Australia. J O'donnell's co-authors include Peter T. Chapman, Lisa K. Stamp, Murray L. Barclay, Christopher Frampton, Jill James, Derek N.J. Hart, Mei Zhang, Kelly L. Summers, Jill Drake and Chris Frampton and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

J O'donnell

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J O'donnell New Zealand 27 731 380 373 280 264 62 1.8k
Hirobumi Kondo Japan 25 516 0.7× 404 1.1× 177 0.5× 174 0.6× 201 0.8× 85 1.7k
Sergio Gutiérrez‐Ureña Mexico 17 986 1.3× 1.2k 3.2× 416 1.1× 318 1.1× 111 0.4× 46 2.4k
Edoardo Rossi Italy 25 528 0.7× 783 2.1× 310 0.8× 278 1.0× 143 0.5× 58 2.0k
Hideaki Yamabe Japan 21 399 0.5× 229 0.6× 577 1.5× 192 0.7× 246 0.9× 91 2.0k
E Pettersson Sweden 23 577 0.8× 379 1.0× 710 1.9× 314 1.1× 1.2k 4.4× 57 2.7k
C. G. M. Kallenberg Netherlands 22 558 0.8× 770 2.0× 218 0.6× 187 0.7× 1.1k 4.2× 46 2.0k
Wilhelm H. Schmitt Germany 26 878 1.2× 537 1.4× 334 0.9× 248 0.9× 1.9k 7.1× 57 2.5k
Luis H. Silveira United States 20 762 1.0× 329 0.9× 152 0.4× 149 0.5× 128 0.5× 48 1.4k
Eleanor L. Ramos United States 21 225 0.3× 354 0.9× 293 0.8× 933 3.3× 400 1.5× 43 2.5k
C.J. Haagsma Netherlands 20 2.0k 2.8× 479 1.3× 197 0.5× 266 0.9× 62 0.2× 38 2.8k

Countries citing papers authored by J O'donnell

Since Specialization
Citations

This map shows the geographic impact of J O'donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J O'donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J O'donnell more than expected).

Fields of papers citing papers by J O'donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J O'donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J O'donnell. The network helps show where J O'donnell may publish in the future.

Co-authorship network of co-authors of J O'donnell

This figure shows the co-authorship network connecting the top 25 collaborators of J O'donnell. A scholar is included among the top collaborators of J O'donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J O'donnell. J O'donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
O'donnell, J, et al.. (2022). Prevalence, incidence and survival outcomes of cardiac sarcoidosis in the South Island, New Zealand. International Journal of Cardiology. 357. 128–133. 4 indexed citations
5.
Spellerberg, Myfanwy B., et al.. (2020). Anti-pneumococcal antibody measurement: implications of discordance between second and third generation assays. Pathology. 52(3). 375–377. 1 indexed citations
6.
Wright, Sarah, et al.. (2017). Management of Gout in a Hospital Setting: A Lost Opportunity. The Journal of Rheumatology. 44(10). 1493–1498. 9 indexed citations
7.
Stamp, Lisa K., Peter T. Chapman, Lutz Beckert, et al.. (2015). Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand. Arthritis Research & Therapy. 17(1). 333–333. 14 indexed citations
8.
Chapman, Peter T., et al.. (2012). Wegener's granulomatosis: treatment and survival characteristics in a high‐prevalence southern hemisphere region. Internal Medicine Journal. 42(4). e23–6. 7 indexed citations
9.
Stamp, Lisa K., et al.. (2011). The Christchurch earthquake—providing a rheumatology service during a natural disaster. Clinical Rheumatology. 31(4). 723–725. 3 indexed citations
10.
Stamp, Lisa K., J O'donnell, Peter T. Chapman, et al.. (2010). Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long‐term methotrexate therapy. Arthritis & Rheumatism. 62(2). 359–368. 68 indexed citations
11.
Stamp, Lisa K., J O'donnell, Peter T. Chapman, et al.. (2009). Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long‐term methotrexate treatment. Arthritis & Rheumatism. 60(8). 2248–2256. 81 indexed citations
12.
Stamp, Lisa K., et al.. (2008). Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 58(11). 3299–3308. 152 indexed citations
13.
Hollis‐Moffatt, Jade E., Marilyn E. Merriman, Peter T. Chapman, et al.. (2008). Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Annals of the Rheumatic Diseases. 68(8). 1340–1344. 35 indexed citations
14.
McKinney, Cushla, Marilyn E. Merriman, Peter T. Chapman, et al.. (2007). Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Annals of the Rheumatic Diseases. 67(3). 409–413. 124 indexed citations
15.
Stamp, Lisa K., et al.. (2006). Gout in renal transplant recipients. Nephrology. 11(4). 367–371. 26 indexed citations
16.
Stamp, Lisa K., Rebecca Roberts, Martin A. Kennedy, et al.. (2006). The use of low dose methotrexate in rheumatoid arthritis—are we entering a new era of therapeutic drug monitoring and pharmacogenomics?. Biomedicine & Pharmacotherapy. 60(10). 678–687. 39 indexed citations
17.
Möller, Peter, et al.. (2005). Adult‐onset inflammatory myopathy: North Canterbury experience 1989–2001. Internal Medicine Journal. 35(3). 170–173. 32 indexed citations
18.
Summers, Kelly L., J O'donnell, Lisa A. Williams, & Derek N.J. Hart. (1996). Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis. Arthritis & Rheumatism. 39(8). 1287–1291. 30 indexed citations
19.
Summers, Kelly L., et al.. (1995). Improved Isolation of Dendritic Cells in Chronic Arthritic Joints Reveals No B7 (CD80) Surface Expression. Advances in experimental medicine and biology. 378. 561–563. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirobumi Kondo Breakdown of academic impact, for papers by Sergio Gutiérrez‐Ureña Breakdown of academic impact, for papers by Edoardo Rossi Breakdown of academic impact, for papers by Hideaki Yamabe Breakdown of academic impact, for papers by E Pettersson Breakdown of academic impact, for papers by C. G. M. Kallenberg Breakdown of academic impact, for papers by Wilhelm H. Schmitt Breakdown of academic impact, for papers by Luis H. Silveira Breakdown of academic impact, for papers by Eleanor L. Ramos Breakdown of academic impact, for papers by C.J. Haagsma
Rankless by CCL
2026